10 studies found for:    "Abruptio Placentae"
Show Display Options
Rank Status Study
1 Unknown  The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta
Conditions: Pregnancy Related;   Trauma;   Abruptio Placentae
Intervention:
2 Recruiting Magnesium Sulfate vs Placebo for Placental Abruption
Condition: Abruptio Placentae
Interventions: Drug: Magnesium Sulfate;   Other: Normal Saline
3 Not yet recruiting Progesterone for First Trimester Vaginal Bleeding
Conditions: Threatened Abortion;   Pre-Eclampsia;   Abruptio Placentae;   Fetal Growth Retardation;   Premature Birth
Interventions: Drug: dihydroxyprogesterone caproate;   Drug: Placebo
4 Completed Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Conditions: Cerebral Palsy;   Intraventricular Hemorrhage;   Periventricular Leukomalacia;   Pulmonary Edema;   Abruptio Placentae
Intervention: Drug: magnesium sulfate
5 Recruiting Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome
Conditions: Fetal Demise;   Fetal Growth Restriction;   Preeclampsia;   Abruptio Placentae;   Thromboembolism
Intervention: Drug: enoxaparin
6 Active, not recruiting Proof of Concept Study of a Sucker Hemostatic Intra Uterine in Postpartum Hemorrhage After Abruptio Placenta Assisted
Conditions: No Placental Abruption;   No Hemorrhage
Intervention: Device: Suction cup Hemostatic Intra-Uterine, device not marked CE (not marketed)
7 Unknown  Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity
Conditions: Pregnancy Complications;   Preeclampsia;   Placental Abruption;   Intrauterine Fetal Growth Restriction;   Intrauterine Fetal Death
Intervention:
8 Recruiting Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia
Condition: Preeclampsia
Interventions: Drug: Lovenox® (enoxaparin);   Drug: Aspegic ® (Aspirin)
9 Not yet recruiting Low Dose Aspirin for the Prevention of Preeclampsia
Condition: Preeclampsia
Interventions: Drug: Aspirin;   Drug: Placebo
10 Completed Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies
Condition: High Risk Pregnancy
Interventions: Drug: PETN;   Drug: Placebo control

Indicates status has not been verified in more than two years